Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Up-regulation of CDHR5 expression promotes malignant phenotype of pancreatic ductal adenocarcinoma.

Journal of cellular and molecular medicine - 1 Nov 2020

Gao Junyi, Wang Mengyi, Li Tong, Liu Qiaofei, You Lei, Liao Quan

Abstract excerpt

CDHR5 has been reported to play key roles in carcinogenesis of various cancers, but its roles in pancreatic cancer have not been reported. The present study was designed to investigate its clinical value in pancreatic ductal adenocarcinoma (PDAC). Tissue microarray-based immunohistochemistry was performed to analyse the correlation between CDHR5 expression and clinical and pathological features of PDAC, as well...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cadherin Related Proteins
Share to Cadherins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Pancreatic Ductal

Share to Kaplan-Meier Estimate

Share to Neoplasm Invasiveness

Share to Proportional Hazards Models

Share to Protein Isoforms

Share to Up-Regulation

Source

Open in PubMed Open full text

Identifiers

PMID: 33025744
DOI: 10.1111/jcmm.15856
PMCID: PMC7687006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Up-regulation of CDHR5 expression promotes malignant phenotype of pancreatic ductal adenocarcinoma.PMID 33025744Read ↗

Prognostic and Functional Significance of MAP4K5 in Pancreatic CancerSemantic proximity Read ↗

Bioinformatics analysis combined with experiments to explore potential prognostic factors for pancreatic cancerSemantic proximity Read ↗

Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinomaSemantic proximity Read ↗

Association of RAB5 overexpression in pancreatic cancer with cancer progression and poor prognosis via E-cadherin suppressionSemantic proximity Read ↗

EphA4 receptor, overexpressed in pancreatic ductal adenocarcinoma, promotes cancer cell growthSemantic proximity Read ↗

KDM5 family of demethylases promotes CD44-mediated chemoresistance in pancreatic adenocarcinomasSemantic proximity Read ↗

Grainyhead-like 2 (GRHL2) regulates epithelial plasticity in pancreatic cancer progression.Semantic proximity Read ↗

ERAP2 as a potential biomarker for predicting gemcitabine response in patients with pancreatic cancerSemantic proximity Read ↗

HMMR is a prognostic-related biomarker of p ancreatic ductal adenocarcinoma and promotes the development of p ancreatic ductal adenocarcinomaSemantic proximity Read ↗

Significance of the E3 ubiquitin protein UBR5 as an oncogene and a prognostic biomarker in colorectal cancerSemantic proximity Read ↗

Gene Regulation by Antitumor miR-204-5p in Pancreatic Ductal Adenocarcinoma: The Clinical Significance of Direct RACGAP1 RegulationSemantic proximity Read ↗

Overexpression of Laminin-5 Gamma-2 promotes tumorigenesis of pancreatic ductal adenocarcinoma through EGFR/ERK1/2/AKT/mTOR cascadeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.